EDN1 and atherosclerosis: Endothelin (predominantly endothelin-1, ET-1) via its receptors (ETA and/or ETB) triggers vasoconstriction (both systemic as well as pulmonary), promotes inflammation, oxidative damage, fibrinogenesis, and atherosclerosis, and is involved in salt and water regulation [23–25].